The Mumbai based
NSE 0.10 % has signed an in-licensing agreement with Italian pharmaceutical company Cassiopea SpA to sell Winlevi (clascoterone cream 1%) in the United States and Canada.
Winlevi has been approved by the United States Food & Drug Administration (FDA) as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older, according to a compa ..